Form 8-K - Current report:
SEC Accession No. 0000950170-24-070574
Filing Date
2024-06-07
Accepted
2024-06-07 16:03:44
Documents
13
Period of Report
2024-06-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K gern-20240606.htm   iXBRL 8-K 43612
2 EX-99.1 gern-ex99_1.htm EX-99.1 47884
3 GRAPHIC img50521483_0.jpg GRAPHIC 3209
  Complete submission text file 0000950170-24-070574.txt   222130

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT gern-20240606.xsd EX-101.SCH 28077
16 EXTRACTED XBRL INSTANCE DOCUMENT gern-20240606_htm.xml XML 4697
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 241029225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)